Our CEO Adrien Nivoliez and Business Development Manager Richard Ellis hosted an online panel discussion along with Mary Poor (VP CMC/Quality at Siolta Therapeutics) and Luc Dubois (Director at Validapro) to discuss developing a robust regulatory strategy for Live Biotherapeutic Manufacturing

Download the slides and watch the panel here in case you missed it live and do not hesitate to reach out to us at r.ellis@biose.com should you have any questions